The social value of fluphenazine decanoate
- PMID: 799897
The social value of fluphenazine decanoate
Abstract
The Medical Research Council (England) conducted a double blind placebo controlled trial of fluphenazine decanoate as a form of maintenance therapy for schizophrenic out-patients. The results clearly demonstrated the clinical and social value of the drug in minimizing positive psychotic features, in preventing relapse and thereby alleviating distress amongst the parents of single patients and the wives of married patients. The drug allows the patients to fulfill normal social role expectations.
Similar articles
-
A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.J Clin Psychiatry. 1978 Apr;39(4):375-9. J Clin Psychiatry. 1978. PMID: 580285 Clinical Trial.
-
Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.Int Clin Psychopharmacol. 1992 Nov;7(2):67-72. Int Clin Psychopharmacol. 1992. PMID: 1487623 Clinical Trial.
-
Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.J Clin Psychiatry. 1982 May;43(5):195-6. J Clin Psychiatry. 1982. PMID: 7076630
-
The use of depot neuroleptics: clinical experience in the United States.J Clin Psychiatry. 1984 May;45(5 Pt 2):5-12. J Clin Psychiatry. 1984. PMID: 6370987 Review.
-
Maintenance therapy and schizophrenia.Br J Psychiatry. 1975;Spec No 9:55-8. Br J Psychiatry. 1975. PMID: 241453 Review. No abstract available.
Cited by
-
Fluphenazine decanoate (depot) and enanthate for schizophrenia.Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Cochrane Database Syst Rev. 2015. PMID: 25654768 Free PMC article.
-
Maintenance treatment with antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev. 2020 Aug 11;8(8):CD008016. doi: 10.1002/14651858.CD008016.pub3. Cochrane Database Syst Rev. 2020. PMID: 32840872 Free PMC article.
-
A review of patient outcomes in pharmacological studies from the psychiatric literature, 1966-1993.Sci Eng Ethics. 1997 Oct;3(4):395-406. doi: 10.1007/s11948-997-0043-1. Sci Eng Ethics. 1997. PMID: 11658032 No abstract available.
-
Fluphenazine (oral) versus placebo for schizophrenia.Cochrane Database Syst Rev. 2018 Jun 12;6(6):CD006352. doi: 10.1002/14651858.CD006352.pub3. Cochrane Database Syst Rev. 2018. PMID: 29893410 Free PMC article.
-
Fluphenazine (oral) versus placebo for schizophrenia.Cochrane Database Syst Rev. 2013 Jul 17;7(7):CD006352. doi: 10.1002/14651858.CD006352.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2018 Jun 12;6:CD006352. doi: 10.1002/14651858.CD006352.pub3. PMID: 23861067 Free PMC article. Updated.